109 related articles for article (PubMed ID: 12231381)
21. The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors.
Hoestgaard-Jensen K; O'Connor RM; Dalby NO; Simonsen C; Finger BC; Golubeva A; Hammer H; Bergmann ML; Kristiansen U; Krogsgaard-Larsen P; Bräuner-Osborne H; Ebert B; Frølund B; Cryan JF; Jensen AA
Br J Pharmacol; 2013 Oct; 170(4):919-32. PubMed ID: 23957253
[TBL] [Abstract][Full Text] [Related]
22. Benzodiazepine and barbiturate ligands modulate responses of cultured hippocampal neurones to the GABAA receptor partial agonist, 4-PIOL.
Kristiansen U; Lambert JD
Neuropharmacology; 1996; 35(9-10):1181-91. PubMed ID: 9014133
[TBL] [Abstract][Full Text] [Related]
23. The GABAA antagonist DPP-4-PIOL selectively antagonises tonic over phasic GABAergic currents in dentate gyrus granule cells.
Boddum K; Frølund B; Kristiansen U
Neurochem Res; 2014 Nov; 39(11):2078-84. PubMed ID: 25103229
[TBL] [Abstract][Full Text] [Related]
24. Coupling between agonist and chloride ionophore sites of the GABA(A) receptor: agonist/antagonist efficacy of 4-PIOL.
Rabe H; Picard R; Uusi-Oukari M; Hevers W; Lüddens H; Korpi ER
Eur J Pharmacol; 2000 Dec; 409(3):233-42. PubMed ID: 11108817
[TBL] [Abstract][Full Text] [Related]
25. Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors.
Ebert B; Thompson SA; Saounatsou K; McKernan R; Krogsgaard-Larsen P; Wafford KA
Mol Pharmacol; 1997 Dec; 52(6):1150-6. PubMed ID: 9396785
[TBL] [Abstract][Full Text] [Related]
26. Conformational analysis and molecular modelling of a partial GABAA agonist and a glycine antagonist related to the GABAA agonist, THIP.
Buur JR; Hjeds H; Krogsgaard-Larsen P; Jørgensen FS
Drug Des Discov; 1993; 10(3):213-29. PubMed ID: 8268393
[TBL] [Abstract][Full Text] [Related]
27. Differential interactions of 5-(4-piperidyl)-3-isoxazolol analogues with insect γ-aminobutyric acid receptors leading to functional selectivity.
Liu G; Frølund B; Ozoe F; Ozoe Y
Insect Biochem Mol Biol; 2015 Nov; 66():64-71. PubMed ID: 26453818
[TBL] [Abstract][Full Text] [Related]
28. Evidence for inhibitory effect of the agonist gaboxadol at human alpha 1 beta 2 gamma 2S GABAA receptors.
Smith M; Lindquist CE; Birnir B
Eur J Pharmacol; 2003 Sep; 478(1):21-6. PubMed ID: 14555180
[TBL] [Abstract][Full Text] [Related]
29. Aza-THIP and related analogues of THIP as GABA C antagonists.
Krehan D; Frølund B; Ebert B; Nielsen B; Krogsgaard-Larsen P; Johnston GA; Chebib M
Bioorg Med Chem; 2003 Nov; 11(23):4891-6. PubMed ID: 14604650
[TBL] [Abstract][Full Text] [Related]
30. GABA(A) receptor ligands and their therapeutic potentials.
Frølund B; Ebert B; Kristiansen U; Liljefors T; Krogsgaard-Larsen P
Curr Top Med Chem; 2002 Aug; 2(8):817-32. PubMed ID: 12171573
[TBL] [Abstract][Full Text] [Related]
31. Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination.
Thompson SA; Whiting PJ; Wafford KA
Br J Pharmacol; 1996 Feb; 117(3):521-527. PubMed ID: 8821543
[TBL] [Abstract][Full Text] [Related]
32. Differences in kinetics of structurally related competitive GABA(A) receptor antagonists.
Vestergaard HT; Cannillo C; Frølund B; Kristiansen U
Neuropharmacology; 2007 Mar; 52(3):873-82. PubMed ID: 17125806
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology of GABA rho 1 and GABA alpha/beta receptors expressed in Xenopus oocytes and COS cells.
Kusama T; Spivak CE; Whiting P; Dawson VL; Schaeffer JC; Uhl GR
Br J Pharmacol; 1993 May; 109(1):200-6. PubMed ID: 8388298
[TBL] [Abstract][Full Text] [Related]
34. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.
Ebert B; Wafford KA; Whiting PJ; Krogsgaard-Larsen P; Kemp JA
Mol Pharmacol; 1994 Nov; 46(5):957-63. PubMed ID: 7969086
[TBL] [Abstract][Full Text] [Related]
35. The low efficacy gamma-aminobutyric acid type A agonist 5-(4-piperidyl)isoxazol-3-ol opens brief Cl- channels in embryonic rat olfactory bulb neurons.
Kristiansen U; Barker JL; Serafini R
Mol Pharmacol; 1995 Aug; 48(2):268-79. PubMed ID: 7651360
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiological studies of the GABAA receptor ligand, 4-PIOL, on cultured hippocampal neurones.
Kristiansen U; Lambert JD; Falch E; Krogsgaard-Larsen P
Br J Pharmacol; 1991 Sep; 104(1):85-90. PubMed ID: 1664767
[TBL] [Abstract][Full Text] [Related]
37. Characterization of bicuculline/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists.
Woodward RM; Polenzani L; Miledi R
Mol Pharmacol; 1993 Apr; 43(4):609-25. PubMed ID: 8386310
[TBL] [Abstract][Full Text] [Related]
38. Agonist pharmacology of two Drosophila GABA receptor splice variants.
Hosie AM; Sattelle DB
Br J Pharmacol; 1996 Dec; 119(8):1577-85. PubMed ID: 8982504
[TBL] [Abstract][Full Text] [Related]
39. Mutation at the putative GABA(A) ion-channel gate reveals changes in allosteric modulation.
Thompson SA; Smith MZ; Wingrove PB; Whiting PJ; Wafford KA
Br J Pharmacol; 1999 Jul; 127(6):1349-58. PubMed ID: 10455284
[TBL] [Abstract][Full Text] [Related]
40. 3- and 5-isoxazolol zwitterions: an ab initio molecular orbital study relating to GABA agonism and antagonism.
Boulanger T; Vercauteren DP; Durant F; Andre JM
J Theor Biol; 1987 Aug; 127(4):479-89. PubMed ID: 2832660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]